Molecular Templates Stock (NASDAQ:MTEM), Quotes and News Summary

Q: What sector and industry does Molecular Templates (MTEM) operate in?

Molecular Templates is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Molecular Templates Stock (NASDAQ: MTEM) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 61.443K
Day Range	- - -
52 Wk Range	1.450 - 9.450
Market Cap	$10.403M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	0.67%
Days to Cover	1

Recent News

What's Going On With Molecular Templates Stock?

Molecular Templates shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients with PD-L1+ solid tumors. Molecular Templates said the findings show that MT-6402 acts uniquely from other approved checkpoint agents and was well-tolerated with no drug-related Grade 4 or Grade 5 adverse events observed. "We are excited to see objective responses in heavily pre-treated, checkpoint-experienced, head and neck cancer patients, a setting with high unmet medical need," said CEO Eric Poma.

Erica Kollmann

Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Avi Kapoor

Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About Molecular Templates Inc

Sector

Health Care

Industry

Biotechnology

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeu...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Molecular Templates (MTEM) stock?

You can purchase shares of Molecular Templates (NASDAQ: MTEM) through any online brokerage.

View our list of the best stock brokerages.

Who are Molecular Templates's (MTEM) competitors?

Other companies in Molecular Templates’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Can Fite Biofarma (AMEX:CANF).

What is the target price for Molecular Templates (MTEM) stock?

The latest price target for Molecular Templates (NASDAQ: MTEM) was reported by Barclays on Friday, November 11, 2022. The analyst firm set a price target for 1.00 expecting MTEM to fall to within 12 months (a possible -36.71% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Molecular Templates (MTEM)?

The stock price for Molecular Templates (NASDAQ: MTEM) is $1.58 last updated April 18, 2024 at 9:25 AM EDT.

Does Molecular Templates (MTEM) pay a dividend?

There are no upcoming dividends for Molecular Templates.

When is Molecular Templates (NASDAQ:MTEM) reporting earnings?

Molecular Templates’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Molecular Templates (MTEM) going to split?

There is no upcoming split for Molecular Templates.

What sector and industry does Molecular Templates (MTEM) operate in?

Molecular Templates is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-